{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T19:23:27Z","timestamp":1780601007012,"version":"3.54.1"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,1,7]],"date-time":"2022-01-07T00:00:00Z","timestamp":1641513600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,1,7]],"date-time":"2022-01-07T00:00:00Z","timestamp":1641513600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"grant-in-aid for Scientific Research in Japan"},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Invasive dental treatment such as tooth extraction following treatment with strong anti-bone resorptive agents, including bisphosphonates and denosumab, reportedly promotes osteonecrosis of the jaw (ONJ) at the extraction site, but strategies to prevent ONJ remain unclear. Here we show that in mice, administration of either active vitamin D analogues, antibiotics or anti-inflammatory agents can prevent ONJ development induced by tooth extraction during treatment with the bisphosphonate zoledronate. Specifically, tooth extraction during treatment with zoledronate induced osteonecrosis in mice, but administration of either 1,25(OH)<jats:sub>2<\/jats:sub>D<jats:sub>3<\/jats:sub> or ED71, both active vitamin D analogues, significantly antagonized osteonecrosis development, even under continuous zoledronate treatment. 1,25(OH)<jats:sub>2<\/jats:sub>D<jats:sub>3<\/jats:sub> or ED71 administration also significantly inhibited osteocyte apoptosis induced by tooth extraction and bisphosphonate treatment. Administration of either active vitamin D analogue significantly inhibited elevation of serum inflammatory cytokine levels in mice in response to injection of lipopolysaccharide, an infection mimetic. Furthermore, administration of either anti-inflammatory or antibiotic reagents significantly blocked ONJ development following tooth extraction and zoledronate treatment. These findings suggest that administration of active vitamin D, anti-inflammatory agents or antibiotics could prevent ONJ development induced by tooth extraction in patients treated with zoledronate.<\/jats:p>","DOI":"10.1038\/s41598-021-03966-6","type":"journal-article","created":{"date-parts":[[2022,1,7]],"date-time":"2022-01-07T11:03:34Z","timestamp":1641553414000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Osteonecrosis development by tooth extraction in zoledronate treated mice is inhibited by active vitamin D analogues, anti-inflammatory agents or antibiotics"],"prefix":"10.1038","volume":"12","author":[{"given":"Tomoya","family":"Soma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryotaro","family":"Iwasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuiko","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tami","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eri","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuaki","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kana","family":"Miyamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morio","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaya","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayu","family":"Morita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seiji","family":"Asoda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiromasa","family":"Kawana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taneaki","family":"Nakagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Miyamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,1,7]]},"reference":[{"key":"3966_CR1","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/s8756-3282(99)00105-2","volume":"25","author":"BF Boyce","year":"1999","unstructured":"Boyce, B. F., Xing, L., Franzoso, G. & Siebenlist, U. Required and nonessential functions of nuclear factor-kappa B in bone cells. Bone 25, 137\u2013139. https:\/\/doi.org\/10.1016\/s8756-3282(99)00105-2 (1999).","journal-title":"Bone"},{"key":"3966_CR2","doi-asserted-by":"publisher","first-page":"3482","DOI":"10.1101\/gad.11.24.3482","volume":"11","author":"G Franzoso","year":"1997","unstructured":"Franzoso, G. et al. Requirement for NF-kappaB in osteoclast and B-cell development. Genes Dev. 11, 3482\u20133496. https:\/\/doi.org\/10.1101\/gad.11.24.3482 (1997).","journal-title":"Genes Dev."},{"key":"3966_CR3","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1634\/theoncologist.2010-0183","volume":"16","author":"RA Miksad","year":"2011","unstructured":"Miksad, R. A. et al. Quality of life implications of bisphosphonate-associated osteonecrosis of the jaw. Oncologist 16, 121\u2013132. https:\/\/doi.org\/10.1634\/theoncologist.2010-0183 (2011).","journal-title":"Oncologist"},{"key":"3966_CR4","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.oooo.2020.03.051","volume":"130","author":"T Sato","year":"2020","unstructured":"Sato, T. et al. Which symptoms negatively affect the oral health-related quality of life in patients with osteonecrosis of the jaw?. Oral Surg Oral Med Oral Pathol Oral Radiol 130, 175\u2013180. https:\/\/doi.org\/10.1016\/j.oooo.2020.03.051 (2020).","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"3966_CR5","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.4065\/83.9.1032","volume":"83","author":"MT Drake","year":"2008","unstructured":"Drake, M. T., Clarke, B. L. & Khosla, S. Bisphosphonates: Mechanism of action and role in clinical practice. Mayo Clin. Proc. 83, 1032\u20131045. https:\/\/doi.org\/10.4065\/83.9.1032 (2008).","journal-title":"Mayo Clin. Proc."},{"key":"3966_CR6","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1001\/jama.2018.13773","volume":"320","author":"R Mhaskar","year":"2018","unstructured":"Mhaskar, R. & Djulbegovic, B. Bisphosphonates for patients diagnosed with multiple myeloma. JAMA 320, 1483\u20131484. https:\/\/doi.org\/10.1001\/jama.2018.13773 (2018).","journal-title":"JAMA"},{"key":"3966_CR7","doi-asserted-by":"publisher","first-page":"2347","DOI":"10.1200\/jco.2012.47.7901","volume":"31","author":"E Terpos","year":"2013","unstructured":"Terpos, E. et al. International Myeloma Working Group recommendations for the treatment of multiple myeloma-related bone disease. J. Clin. Oncol. 31, 2347\u20132357. https:\/\/doi.org\/10.1200\/jco.2012.47.7901 (2013).","journal-title":"J. Clin. Oncol."},{"key":"3966_CR8","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.beha.2005.03.001","volume":"18","author":"JR Berenson","year":"2005","unstructured":"Berenson, J. R. Myeloma bone disease. Best Pract. Res. Clin. Haematol. 18, 653\u2013672. https:\/\/doi.org\/10.1016\/j.beha.2005.03.001 (2005).","journal-title":"Best Pract. Res. Clin. Haematol."},{"key":"3966_CR9","doi-asserted-by":"publisher","first-page":"2315","DOI":"10.1007\/s00198-018-4621-7","volume":"29","author":"A Shudo","year":"2018","unstructured":"Shudo, A., Kishimoto, H., Takaoka, K. & Noguchi, K. Long-term oral bisphosphonates delay healing after tooth extraction: A single institutional prospective study. Osteoporos. Int. 29, 2315\u20132321. https:\/\/doi.org\/10.1007\/s00198-018-4621-7 (2018).","journal-title":"Osteoporos. Int."},{"key":"3966_CR10","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1016\/j.bone.2008.01.003","volume":"42","author":"R Rizzoli","year":"2008","unstructured":"Rizzoli, R. et al. Osteonecrosis of the jaw and bisphosphonate treatment for osteoporosis. Bone 42, 841\u2013847. https:\/\/doi.org\/10.1016\/j.bone.2008.01.003 (2008).","journal-title":"Bone"},{"key":"3966_CR11","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/j.ijom.2013.02.007","volume":"42","author":"J Abtahi","year":"2013","unstructured":"Abtahi, J., Agholme, F. & Aspenberg, P. Prevention of osteonecrosis of the jaw by mucoperiosteal coverage in a rat model. Int. J. Oral Maxillofac. Surg. 42, 632\u2013636. https:\/\/doi.org\/10.1016\/j.ijom.2013.02.007 (2013).","journal-title":"Int. J. Oral Maxillofac. Surg."},{"key":"3966_CR12","doi-asserted-by":"publisher","first-page":"46322","DOI":"10.1038\/srep46322","volume":"7","author":"M Morita","year":"2017","unstructured":"Morita, M. et al. Elevation of pro-inflammatory cytokine levels following anti-resorptive drug treatment is required for osteonecrosis development in infectious osteomyelitis. Sci. Rep. 7, 46322. https:\/\/doi.org\/10.1038\/srep46322 (2017).","journal-title":"Sci. Rep."},{"key":"3966_CR13","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.ijom.2018.07.002","volume":"48","author":"A Shuster","year":"2019","unstructured":"Shuster, A. et al. Comparison of the histopathological characteristics of osteomyelitis, medication-related osteonecrosis of the jaw, and osteoradionecrosis. Int. J. Oral Maxillofac. Surg. 48, 17\u201322. https:\/\/doi.org\/10.1016\/j.ijom.2018.07.002 (2019).","journal-title":"Int. J. Oral Maxillofac. Surg."},{"key":"3966_CR14","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.bone.2011.02.003","volume":"49","author":"RE Coleman","year":"2011","unstructured":"Coleman, R. E. & McCloskey, E. V. Bisphosphonates in oncology. Bone 49, 71\u201376. https:\/\/doi.org\/10.1016\/j.bone.2011.02.003 (2011).","journal-title":"Bone"},{"key":"3966_CR15","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1007\/s11864-019-0623-8","volume":"20","author":"H Goldvaser","year":"2019","unstructured":"Goldvaser, H. & Amir, E. Role of bisphosphonates in breast cancer therapy. Curr. Treat. Options Oncol. 20, 26. https:\/\/doi.org\/10.1007\/s11864-019-0623-8 (2019).","journal-title":"Curr. Treat. Options Oncol."},{"key":"3966_CR16","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1007\/s00198-018-4460-6","volume":"29","author":"KE Naylor","year":"2018","unstructured":"Naylor, K. E. et al. Effects of discontinuing oral bisphosphonate treatments for postmenopausal osteoporosis on bone turnover markers and bone density. Osteoporos. Int. 29, 1407\u20131417. https:\/\/doi.org\/10.1007\/s00198-018-4460-6 (2018).","journal-title":"Osteoporos. Int."},{"key":"3966_CR17","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1007\/s00774-020-01174-2","volume":"39","author":"T Soma","year":"2021","unstructured":"Soma, T. et al. Tooth extraction in mice administered zoledronate increases inflammatory cytokine levels and promotes osteonecrosis of the jaw. J. Bone Miner. Metab. 39, 372\u2013384. https:\/\/doi.org\/10.1007\/s00774-020-01174-2 (2021).","journal-title":"J. Bone Miner. Metab."},{"key":"3966_CR18","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1007\/s11914-017-0394-8","volume":"15","author":"PH Anderson","year":"2017","unstructured":"Anderson, P. H. Vitamin D activity and metabolism in bone. Curr Osteoporos Rep 15, 443\u2013449. https:\/\/doi.org\/10.1007\/s11914-017-0394-8 (2017).","journal-title":"Curr Osteoporos Rep"},{"key":"3966_CR19","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1021\/jm00211a002","volume":"20","author":"RL Johnson","year":"1977","unstructured":"Johnson, R. L., Carey, S. C., Norman, A. W. & Okamura, W. H. Studies on vitamin D (calciferol) and its analogues. 10. Side-chain analogues of 25-hydroxyvitamin D3. J. Med. Chem. 20, 5\u201311. https:\/\/doi.org\/10.1021\/jm00211a002 (1977).","journal-title":"J. Med. Chem."},{"key":"3966_CR20","doi-asserted-by":"publisher","first-page":"3271","DOI":"10.2169\/internalmedicine.8618-16","volume":"56","author":"K Nitta","year":"2017","unstructured":"Nitta, K., Yajima, A. & Tsuchiya, K. Management of osteoporosis in chronic kidney disease. Intern. Med. 56, 3271\u20133276. https:\/\/doi.org\/10.2169\/internalmedicine.8618-16 (2017).","journal-title":"Intern. Med."},{"key":"3966_CR21","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1111\/ajco.12517","volume":"13","author":"K Pittman","year":"2017","unstructured":"Pittman, K., Antill, Y. C., Goldrick, A., Goh, J. & de Boer, R. H. Denosumab: Prevention and management of hypocalcemia, osteonecrosis of the jaw and atypical fractures. Asia Pac. J. Clin. Oncol. 13, 266\u2013276. https:\/\/doi.org\/10.1111\/ajco.12517 (2017).","journal-title":"Asia Pac. J. Clin. Oncol."},{"key":"3966_CR22","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/j.bone.2015.08.004","volume":"81","author":"S Sakai","year":"2015","unstructured":"Sakai, S. et al. Treatment with the combination of ibandronate plus eldecalcitol has a synergistic effect on inhibition of bone resorption without suppressing bone formation in ovariectomized rats. Bone 81, 449\u2013458. https:\/\/doi.org\/10.1016\/j.bone.2015.08.004 (2015).","journal-title":"Bone"},{"key":"3966_CR23","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1002\/jbmr.555","volume":"27","author":"S Harada","year":"2012","unstructured":"Harada, S. et al. Daily administration of eldecalcitol (ED-71), an active vitamin D analog, increases bone mineral density by suppressing RANKL expression in mouse trabecular bone. J. Bone Miner. Res. 27, 461\u2013473. https:\/\/doi.org\/10.1002\/jbmr.555 (2012).","journal-title":"J. Bone Miner. Res."},{"key":"3966_CR24","doi-asserted-by":"publisher","first-page":"17349","DOI":"10.1074\/jbc.M115.652305","volume":"290","author":"S Park","year":"2015","unstructured":"Park, S. et al. Osteonecrosis of the jaw developed in mice: Disease variants regulated by \u03b3\u03b4 T cells in oral mucosal barrier immunity. J. Biol. Chem. 290, 17349\u201317366. https:\/\/doi.org\/10.1074\/jbc.M115.652305 (2015).","journal-title":"J. Biol. Chem."},{"key":"3966_CR25","doi-asserted-by":"publisher","first-page":"20602","DOI":"10.1074\/jbc.M116.735795","volume":"291","author":"Y Sun","year":"2016","unstructured":"Sun, Y. et al. Plasticity of myeloid cells during oral barrier wound healing and the development of bisphosphonate-related osteonecrosis of the jaw. J. Biol. Chem. 291, 20602\u201320616. https:\/\/doi.org\/10.1074\/jbc.M116.735795 (2016).","journal-title":"J. Biol. Chem."},{"key":"3966_CR26","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s00774-009-0128-9","volume":"28","author":"Y Kobayashi","year":"2010","unstructured":"Kobayashi, Y. et al. Zoledronic acid delays wound healing of the tooth extraction socket, inhibits oral epithelial cell migration, and promotes proliferation and adhesion to hydroxyapatite of oral bacteria, without causing osteonecrosis of the jaw, in mice. J. Bone Miner. Metab. 28, 165\u2013175. https:\/\/doi.org\/10.1007\/s00774-009-0128-9 (2010).","journal-title":"J. Bone Miner. Metab."},{"issue":"38","key":"3966_CR27","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1111\/j.1600-0757.2005.00113.x","volume":"2000","author":"SC Holt","year":"2005","unstructured":"Holt, S. C. & Ebersole, J. L. Porphyromonas gingivalis, Treponema denticola, and Tannerella forsythia: The \u201cred complex\u201d, a prototype polybacterial pathogenic consortium in periodontitis. Periodontol. 2000(38), 72\u2013122. https:\/\/doi.org\/10.1111\/j.1600-0757.2005.00113.x (2005).","journal-title":"Periodontol."},{"key":"3966_CR28","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/476068","volume":"2014","author":"J Mysak","year":"2014","unstructured":"Mysak, J. et al. Porphyromonas gingivalis: Major periodontopathic pathogen overview. J Immunol Res 2014, 476068. https:\/\/doi.org\/10.1155\/2014\/476068 (2014).","journal-title":"J Immunol Res"},{"key":"3966_CR29","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1006\/cyto.1997.0329","volume":"10","author":"A Murata","year":"1998","unstructured":"Murata, A. et al. Profiles of circulating inflammatory- and anti-inflammatory cytokines in patients with hemolytic uremic syndrome due to E. coli O157 infection. Cytokine 10, 544\u2013548. https:\/\/doi.org\/10.1006\/cyto.1997.0329 (1998).","journal-title":"Cytokine"},{"key":"3966_CR30","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1177\/1933719109333662","volume":"16","author":"D Yafeng","year":"2009","unstructured":"Yafeng, D., Weijian, H., Jiaxue, W. & Weiner, C. P. Chronic hypoxemia absent bacterial infection is one cause of the fetal inflammatory response syndrome (FIRS). Reprod. Sci. 16, 650\u2013656. https:\/\/doi.org\/10.1177\/1933719109333662 (2009).","journal-title":"Reprod. Sci."},{"key":"3966_CR31","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1038\/s41467-018-03147-6","volume":"9","author":"M Tsukasaki","year":"2018","unstructured":"Tsukasaki, M. et al. Host defense against oral microbiota by bone-damaging T cells. Nat. Commun. 9, 701. https:\/\/doi.org\/10.1038\/s41467-018-03147-6 (2018).","journal-title":"Nat. Commun."},{"key":"3966_CR32","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1159\/000151371","volume":"189","author":"MR Allen","year":"2009","unstructured":"Allen, M. R. Bisphosphonates and osteonecrosis of the jaw: Moving from the bedside to the bench. Cells Tissues Organs 189, 289\u2013294. https:\/\/doi.org\/10.1159\/000151371 (2009).","journal-title":"Cells Tissues Organs"},{"key":"3966_CR33","doi-asserted-by":"publisher","first-page":"452737","DOI":"10.1155\/2014\/452737","volume":"2014","author":"AM Hinson","year":"2014","unstructured":"Hinson, A. M., Smith, C. W., Siegel, E. R. & Stack, B. C. Jr. Is bisphosphonate-related osteonecrosis of the jaw an infection? A histological and microbiological ten-year summary. Int. J. Dent. 2014, 452737. https:\/\/doi.org\/10.1155\/2014\/452737 (2014).","journal-title":"Int. J. Dent."},{"key":"3966_CR34","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1056\/NEJMc1100730","volume":"364","author":"H Chtioui","year":"2011","unstructured":"Chtioui, H., Lamine, F. & Daghfous, R. Teriparatide therapy for osteonecrosis of the jaw. N. Engl. J. Med. 364, 1081\u20131082. https:\/\/doi.org\/10.1056\/NEJMc1100730 (2011) (author reply 1082).","journal-title":"N. Engl. J. Med."},{"key":"3966_CR35","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.bone.2008.09.012","volume":"44","author":"IR Reid","year":"2009","unstructured":"Reid, I. R. Osteonecrosis of the jaw: Who gets it, and why?. Bone 44, 4\u201310. https:\/\/doi.org\/10.1016\/j.bone.2008.09.012 (2009).","journal-title":"Bone"},{"key":"3966_CR36","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1007\/s00198-018-4775-3","volume":"30","author":"M Kamimura","year":"2019","unstructured":"Kamimura, M. et al. Long waiting time before tooth extraction may increase delayed wound healing in elderly Japanese. Osteoporos. Int. 30, 621\u2013628. https:\/\/doi.org\/10.1007\/s00198-018-4775-3 (2019).","journal-title":"Osteoporos. Int."},{"key":"3966_CR37","doi-asserted-by":"publisher","first-page":"2396","DOI":"10.1056\/NEJMoa1005361","volume":"363","author":"JD Bashutski","year":"2010","unstructured":"Bashutski, J. D. et al. Teriparatide and osseous regeneration in the oral cavity. N. Engl. J. Med. 363, 2396\u20132405. https:\/\/doi.org\/10.1056\/NEJMoa1005361 (2010).","journal-title":"N. Engl. J. Med."},{"key":"3966_CR38","doi-asserted-by":"publisher","DOI":"10.3390\/antiox10050680","author":"SW On","year":"2021","unstructured":"On, S. W., Cho, S. W., Byun, S. H. & Yang, B. E. Various therapeutic methods for the treatment of medication-related osteonecrosis of the jaw (MRONJ) and their limitations: A narrative review on new molecular and cellular therapeutic approaches. Antioxidants (Basel) https:\/\/doi.org\/10.3390\/antiox10050680 (2021).","journal-title":"Antioxidants (Basel)"},{"key":"3966_CR39","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1210\/endo-122-4-1373","volume":"122","author":"N Takahashi","year":"1988","unstructured":"Takahashi, N. et al. Osteoclast-like cell formation and its regulation by osteotropic hormones in mouse bone marrow cultures. Endocrinology 122, 1373\u20131382. https:\/\/doi.org\/10.1210\/endo-122-4-1373 (1988).","journal-title":"Endocrinology"},{"key":"3966_CR40","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1007\/s00774-009-0084-4","volume":"27","author":"S Sakai","year":"2009","unstructured":"Sakai, S. et al. 1-Alpha, 25-dihydroxy vitamin D3 inhibits osteoclastogenesis through IFN-beta-dependent NFATc1 suppression. J. Bone Miner. Metab. 27, 643\u2013652. https:\/\/doi.org\/10.1007\/s00774-009-0084-4 (2009).","journal-title":"J. Bone Miner. Metab."},{"key":"3966_CR41","doi-asserted-by":"publisher","first-page":"33","DOI":"10.2302\/kjm.2015-0010-OA","volume":"65","author":"T Miyamoto","year":"2016","unstructured":"Miyamoto, T. et al. Vitamin D deficiency with high intact PTH levels is more common in younger than in older women: A study of women aged 39\u201364 years. Keio J. Med. 65, 33\u201338. https:\/\/doi.org\/10.2302\/kjm.2015-0010-OA (2016).","journal-title":"Keio J. Med."},{"key":"3966_CR42","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1093\/annonc\/mdr435","volume":"23","author":"F Saad","year":"2012","unstructured":"Saad, F. et al. Incidence, risk factors, and outcomes of osteonecrosis of the jaw: Integrated analysis from three blinded active-controlled phase III trials in cancer patients with bone metastases. Ann. Oncol. 23, 1341\u20131347. https:\/\/doi.org\/10.1093\/annonc\/mdr435 (2012).","journal-title":"Ann. Oncol."},{"key":"3966_CR43","doi-asserted-by":"publisher","first-page":"331","DOI":"10.20945\/2359-3997000000275","volume":"64","author":"F Bandeira","year":"2020","unstructured":"Bandeira, F., Dantas, W. & Bilezikian, J. P. Controversies in the treatment of postmenopausal osteoporosis: How long to treat with bisphosphonates?. Arch. Endocrinol. Metab. 64, 331\u2013336. https:\/\/doi.org\/10.20945\/2359-3997000000275 (2020).","journal-title":"Arch. Endocrinol. Metab."},{"key":"3966_CR44","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1007\/s12020-015-0748-x","volume":"51","author":"RA Adler","year":"2016","unstructured":"Adler, R. A. Duration of anti-resorptive therapy for osteoporosis. Endocrine 51, 222\u2013224. https:\/\/doi.org\/10.1007\/s12020-015-0748-x (2016).","journal-title":"Endocrine"},{"key":"3966_CR45","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.bone.2019.03.027","volume":"123","author":"A Hokugo","year":"2019","unstructured":"Hokugo, A. et al. Rescue bisphosphonate treatment of alveolar bone improves extraction socket healing and reduces osteonecrosis in zoledronate-treated mice. Bone 123, 115\u2013128. https:\/\/doi.org\/10.1016\/j.bone.2019.03.027 (2019).","journal-title":"Bone"},{"key":"3966_CR46","doi-asserted-by":"publisher","first-page":"20002","DOI":"10.18632\/oncotarget.4755","volume":"6","author":"HC Tseng","year":"2015","unstructured":"Tseng, H. C. et al. Bisphosphonate-induced differential modulation of immune cell function in gingiva and bone marrow in vivo: Role in osteoclast-mediated NK cell activation. Oncotarget 6, 20002\u201320025. https:\/\/doi.org\/10.18632\/oncotarget.4755 (2015).","journal-title":"Oncotarget"},{"key":"3966_CR47","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1007\/s00774-017-0872-1","volume":"36","author":"Y Akita","year":"2018","unstructured":"Akita, Y. et al. Effect of anti-angiogenesis induced by chemotherapeutic monotherapy, chemotherapeutic\/bisphosphonate combination therapy and anti-VEGFA mAb therapy on tooth extraction socket healing in mice. J. Bone Miner. Metab. 36, 547\u2013559. https:\/\/doi.org\/10.1007\/s00774-017-0872-1 (2018).","journal-title":"J. Bone Miner. Metab."},{"key":"3966_CR48","doi-asserted-by":"publisher","first-page":"2318","DOI":"10.1016\/j.ajpath.2018.06.019","volume":"188","author":"T Kim","year":"2018","unstructured":"Kim, T. et al. Removal of pre-existing periodontal inflammatory condition before tooth extraction ameliorates medication-related osteonecrosis of the jaw-like lesion in mice. Am. J. Pathol. 188, 2318\u20132327. https:\/\/doi.org\/10.1016\/j.ajpath.2018.06.019 (2018).","journal-title":"Am. J. Pathol."},{"key":"3966_CR49","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1002\/jbmr.2490","volume":"30","author":"RS de Molon","year":"2015","unstructured":"de Molon, R. S. et al. OPG-Fc but not zoledronic acid discontinuation reverses osteonecrosis of the jaws (ONJ) in mice. J. Bone Miner. Res. 30, 1627\u20131640. https:\/\/doi.org\/10.1002\/jbmr.2490 (2015).","journal-title":"J. Bone Miner. Res."},{"key":"3966_CR50","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.bone.2014.07.027","volume":"68","author":"RS de Molon","year":"2014","unstructured":"de Molon, R. S. et al. Spontaneous osteonecrosis of the jaws in the maxilla of mice on antiresorptive treatment: A novel ONJ mouse model. Bone 68, 11\u201319. https:\/\/doi.org\/10.1016\/j.bone.2014.07.027 (2014).","journal-title":"Bone"},{"key":"3966_CR51","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1002\/jbmr.3292","volume":"33","author":"S Kuroshima","year":"2018","unstructured":"Kuroshima, S. et al. Transplantation of noncultured stromal vascular fraction cells of adipose tissue ameliorates osteonecrosis of the jaw-like lesions in mice. J. Bone Miner. Res. 33, 154\u2013166. https:\/\/doi.org\/10.1002\/jbmr.3292 (2018).","journal-title":"J. Bone Miner. Res."},{"key":"3966_CR52","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1002\/jbmr.2985","volume":"32","author":"S Kim","year":"2017","unstructured":"Kim, S. et al. IL-36 induces bisphosphonate-related osteonecrosis of the jaw-like lesions in mice by inhibiting TGF-\u03b2-mediated collagen expression. J. Bone Miner. Res. 32, 309\u2013318. https:\/\/doi.org\/10.1002\/jbmr.2985 (2017).","journal-title":"J. Bone Miner. Res."},{"key":"3966_CR53","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.bone.2018.05.001","volume":"112","author":"S Kuroshima","year":"2018","unstructured":"Kuroshima, S. et al. Prevalence of bisphosphonate-related osteonecrosis of the jaw-like lesions is increased in a chemotherapeutic dose-dependent manner in mice. Bone 112, 177\u2013186. https:\/\/doi.org\/10.1016\/j.bone.2018.05.001 (2018).","journal-title":"Bone"},{"key":"3966_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2020.115611","volume":"143","author":"J Yamashita","year":"2021","unstructured":"Yamashita, J., Sawa, N., Sawa, Y. & Miyazono, S. Effect of bisphosphonates on healing of tooth extraction wounds in infectious osteomyelitis of the jaw. Bone 143, 115611. https:\/\/doi.org\/10.1016\/j.bone.2020.115611 (2021).","journal-title":"Bone"},{"key":"3966_CR55","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1002\/jbmr.2827","volume":"31","author":"RS de Molon","year":"2016","unstructured":"de Molon, R. S. et al. Rheumatoid arthritis exacerbates the severity of osteonecrosis of the jaws (ONJ) in mice. A randomized, prospective, controlled animal study. J. Bone Miner. Res. 31, 1596\u20131607. https:\/\/doi.org\/10.1002\/jbmr.2827 (2016).","journal-title":"J. Bone Miner. Res."},{"key":"3966_CR56","doi-asserted-by":"publisher","DOI":"10.1007\/s00223-021-00890-9","author":"R Kozutsumi","year":"2021","unstructured":"Kozutsumi, R. et al. Zoledronic acid deteriorates soft and hard tissue healing of murine tooth extraction sockets in a dose-dependent manner. Calcif. Tissue Int. https:\/\/doi.org\/10.1007\/s00223-021-00890-9 (2021).","journal-title":"Calcif. Tissue Int."},{"key":"3966_CR57","doi-asserted-by":"publisher","first-page":"115651","DOI":"10.1016\/j.bone.2020.115651","volume":"142","author":"A Makino","year":"2021","unstructured":"Makino, A. et al. Frequent administration of abaloparatide shows greater gains in bone anabolic window and bone mineral density in mice: A comparison with teriparatide. Bone 142, 115651. https:\/\/doi.org\/10.1016\/j.bone.2020.115651 (2021).","journal-title":"Bone"},{"key":"3966_CR58","doi-asserted-by":"publisher","first-page":"4236","DOI":"10.1038\/onc.2013.545","volume":"33","author":"T Mori","year":"2014","unstructured":"Mori, T. et al. TNF\u03b1 promotes osteosarcoma progression by maintaining tumor cells in an undifferentiated state. Oncogene 33, 4236\u20134241. https:\/\/doi.org\/10.1038\/onc.2013.545 (2014).","journal-title":"Oncogene"},{"key":"3966_CR59","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1038\/s41467-020-14285-1","volume":"11","author":"JS Brunner","year":"2020","unstructured":"Brunner, J. S. et al. Environmental arginine controls multinuclear giant cell metabolism and formation. Nat. Commun. 11, 431. https:\/\/doi.org\/10.1038\/s41467-020-14285-1 (2020).","journal-title":"Nat. Commun."},{"key":"3966_CR60","doi-asserted-by":"publisher","first-page":"e0134391","DOI":"10.1371\/journal.pone.0134391","volume":"10","author":"I Gurt","year":"2015","unstructured":"Gurt, I. et al. The Sirt1 activators SRT2183 and SRT3025 inhibit RANKL-induced osteoclastogenesis in bone marrow-derived macrophages and down-regulate Sirt3 in Sirt1 null cells. PLoS ONE 10, e0134391. https:\/\/doi.org\/10.1371\/journal.pone.0134391 (2015).","journal-title":"PLoS ONE"},{"key":"3966_CR61","doi-asserted-by":"publisher","first-page":"e111845","DOI":"10.1371\/journal.pone.0111845","volume":"9","author":"Y Sato","year":"2014","unstructured":"Sato, Y. et al. The vitamin D analogue ED71 but not 1,25(OH)2D3 targets HIF1\u03b1 protein in osteoclasts. PLoS ONE 9, e111845. https:\/\/doi.org\/10.1371\/journal.pone.0111845 (2014).","journal-title":"PLoS ONE"},{"key":"3966_CR62","doi-asserted-by":"publisher","first-page":"12242","DOI":"10.1038\/s41598-020-69021-y","volume":"10","author":"S Nakamura","year":"2020","unstructured":"Nakamura, S. et al. Vitamin D protects against immobilization-induced muscle atrophy via neural crest-derived cells in mice. Sci. Rep. 10, 12242. https:\/\/doi.org\/10.1038\/s41598-020-69021-y (2020).","journal-title":"Sci. Rep."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-03966-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-03966-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-03966-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T19:30:29Z","timestamp":1669318229000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-03966-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,7]]},"references-count":62,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["3966"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-03966-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,7]]},"assertion":[{"value":"3 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 December 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"19"}}